Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lipids and Glucose Under Prospective Surveillance

NCT01313156 is registered in ClinicalTrials.gov with Asklepios proresearch as lead sponsor.

NCT NCT01313156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01313156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lipids and Glucose Under Prospective Surveillance
Lead sponsor
Asklepios proresearch
Phase
Observational
Overall status
Completed
Start date
November 30, 2008
Completion date
August 31, 2019
Enrollment
1,962 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, type 2 diabetes